Saturday, April 2, 2011: 1:00 PM-2:15 PM
Trinity Ballroom (Hilton Anatole)
Abstracts
271
Growing Prevalence of Providencia stuartii at Detroit Medical Center, 2005-2009
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University;
Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University;
Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University;
Sarwan Kumar, MD, Detroit Medical Center, Wayne State University;
Ryan P. Mynatt, PharmD, Detroit Medical Center, Wayne State University;
Jing J. Zhao, PharmD, Detroit Medical Center, Wayne State University;
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Jack D. Sobel, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University
273
Multidrug-Resistant Gram-Negative Bacteria within a Long-Term Acute Care Hospital: a Review of Five Years of Clinical Cultures
Erin O'Fallon, MD, Hebrew Senior Life Institute for Aging Research;
Teresa Fung, Pharm, D, Hebrew Senior Life Institute for Aging Research;
Jonathan Carlson, MD, PhD, Dana Farber Cancer Institute;
Erika D'Agata, MD, MPH, Beth Israel Deaconess Medical Center
274
Investigation of a Pan-Resistant Verona Integron-Encoded Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae
Neil Gupta, MD, Centers for Disease Control and Prevention;
Susan N. Hocevar, MD, Centers for Disease Control and Prevention;
Anthony A. Marfin, MD, MPH, MA, Washington State Dept. of Health;
Karen F. Anderson, BS, MT(ASCP), Centers for Disease Control and Prevention;
Nancye C. Clark, MS, Centers for Disease Control and Prevention;
Duncan R. MacCannell, PhD, Centers for Disease Control and Prevention;
James K. Rasheed, PhD, Centers for Disease Control and Prevention;
Carolyn V. Gould, MD, MSCR, Centers for Disease Control and Prevention;
Brandi M. Limbago, PhD, Centers for Disease Control and Prevention;
Alexander J. Kallen, MD, MPH, Centers for Disease Control and Prevention
275
Epidemiology of Non-Bloodstream Sterile-Site Infections due to Extended Spectrum ß-Lactamase-producing organisms (ESBLs) within a Detroit Health System
Ylinne Lynch, BS, Detroit Medical Center, Wayne State University;
Heather Bowman, BS, Detroit Medical Center, Wayne State University;
Jennifer Veltman, MD, Detroit Medical Center, Wayne State University;
Ryan Tansek, BS, Detroit Medical Center, Wayne State University;
Palaniappan Manickam, MD, MPH, Detroit Medical Center, Wayne State University;
Odaliz Abreulanfranco, MD, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Jing Zhao, PharmD, Detroit Medical Center, Wayne State University;
Jason M. Pogue, Pharm, D, Detroit Medical Center, Wayne State University;
Paul Lephart, Detroit Medical Center, Wayne State University;
George Alangaden, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
Teena Chopra, MD, Detroit Medical Center, Wayne State University
276
Characteristics and Outcomes of Patients Treated with Intravenous Colistin for Multidrug-Resistant Gram-Negative Bacterial Infections
Monica Sharma, DO, Indiana University Medical Center;
Mitchell Goldman, MD, Indiana University Medical Center;
Sharon M. Erdman, PharmD, Wishard Memorial Hospital;
Suellyn J. Sorensen, PharmD, Indiana University Medical Center;
Stephen J. Wilson, MD, MPH, New York Presbyterian Weill Cornell Medical Center
277
Colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem resistant Enterobacteriaceae infections
Kimberley Ku, BS, Detroit Medical Center, Wayne State University;
Judy Moshos, MT, Detroit Medical Center, Wayne State University;
Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University;
Yujing Wang, BS, Detroit Medical Center, Wayne State University;
Ashish Bhargava, Detroit Medical Center, Wayne State University;
Michelle Campbell, BA, Detroit Medical Center, Wayne State University;
Namir Khandker, BS, Detroit Medical Center, Wayne State University;
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University;
Odaliz Abreulanfranco, MD, Detroit Medical Center,Wayne State University;
Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University;
Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University
278
Epidemiology of KPC-Producing Enterobacteriaceae in a Chicago Hospital
Shirley Shores, MA, Northwestern Memorial Hospital;
Maureen K. Bolon, MD, MS, Northwestern University;
Sandra Reiner, RN, BSN, Northwestern Memorial Hospital;
Jean A. Patel, PharmD, Northwestern Memorial Hospital;
Michael J. Postelnick, RPh, BCPS, AQ, ID, Northwestern Memorial Hospital;
Michael Malczynski, BA, Northwestern Memorial Hospital;
Chao Qi, PhD, Northwestern University;
Teresa Zembower, MD, MPH, Northwestern University
279
A Horizontal Approach for Reducing Acinetobacter Device Associated Infections
Heather L. Albert, RN, BSN, Virginia Commonwealth University Medical Center;
Diane E. Heipel, RN, BSN, Virginia Commonwealth University Medical Center;
Connie Atkinson, RN, Virginia Commonwealth University Medical Center;
Kakotan Sanogo, Virginia Commonwealth University Medical Center;
Janis Ober, Virginia Commonwealth University Medical Center;
Gonzalo Bearman, MD, MPH, Virginia Commonwealth University Medical Center;
Michael P. Stevens, MD, Virginia Commonwealth University Medical Center;
Michael B. Edmond, MD, MPH, MPA, Virginia Commonwealth University Medical Center
280
Predictors and outcomes of patients with carbapenem-resistant Enterobacteriaceae co-colonized with Acinetobacter baumannii or Pseudomonas aeruginosa
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
Federico Perez, Cleveland VA Medical Center;
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University;
Palaniappan Manickam, MD, MPH, Detroit Medical Center, Wayne State University;
Paul R. Lephart, PhD, Detroit Medical Center, Wayne State University;
Suchitha Bheemreddy, MD, Detroit Medical Center, Wayne State University;
Bharath Sunkara, MD, Detroit Medical Center, Wayne State University;
Christopher Blunden, BS, Detroit Medical Center,Wayne State University;
Andrea M. Hujer, BA, Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center,;
Susan Rudin, BA, Louis Stokes Cleveland VA Medical Center;
Maryann Shango, BS, Detroit Medical Center, Wayne State University;
Michelle Campbell, BA, Detroit Medical Center, Wayne State University;
Jastin Varkey, BA, Detroit Medical Center, Wayne State University;
Diixa Patel, MD, Detroit Medical Center, Wayne State University;
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Robert A. Bonomo, MD, Louis Stokes Cleveland VA Medical Center;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University
281
Clinical Outcomes of Septic Patients with Carbapenemase Producing Klebsiella pneumoniae at a New York City Hospital
Jacques Simkins, MD, Montefiore Medical Center of Albert Einstein College of Medicine;
Negia Elisa Lalane, MD, Jacobi Medical Center, Albert Einstein College of Medicine;
Sharon Leung, MD, Montefiore Medical Center of Albert Einstein College of Medicine;
Reha Pokharel, MD, Montefiore Medical Center of Albert Einstein College of Medicine;
Brian P. Currie, MD, MPH, Montefiore Medical Center of Albert Einstein College of Medicine
282
Carbapenem Resistant Enterobacteriaceae: Risk Factors and Role of Extended Care Facilities
Andres O. Makarem, MD, Advocate Illinois Masonic Medical Center;
Paola I. Alvarez, MD, Advocate Illinois Masonic Medical Center;
Teresa Chou, MPH, CIC, Advocate Illinois Masonic Medical Center;
Mandavi Kulkarni, MD, Advocate Illinois Masonic Medical Center;
James Kerridge, MA, RN, CIC, Advocate Illinois Masonic Medical Center;
Wickman Katie, MS, RN, Advocate Illinois Masonic Medical Center;
Michael Costello, PhD, ACL Laboratories;
James Malow, MD, FIDSA, Advocate Illinois Masonic Medical Center
283
Comparative Effectiveness of Tigecycline, Polymyxin B, and Aminoglycosides in Eradicating Carbapenem-resistant Klebsiella pneumoniae (CRKP) from the Urine
Michael J. Satlin, MD, Weill Cornell Medical College;
Christine J. Kubin, PharmD, BCPS, Columbia University; NewYork-Presbyterian Hospital;
Jill S. Blumenthal, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center;
Andrew B. Cohen, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center;
E. Yoko Furuya, MD, MS, Columbia University;
Stephen J. Wilson, MD, MPH, Weill Cornell Medical College;
Stephen G. Jenkins, PhD, Weill Cornell Medical College;
David P. Calfee, MD, MS, Weill Cornell Medical College
284
Admission Screening for ESBL-producing Enterobacteriaceae (ESBL-E): Impact on Nosocomial Transmission Over a 6 Year Period
Christopher Fong Jen Lowe, MD, University of Toronto;
Kevin C. Katz, MD, North York General Hospital;
Matthew Paul Muller, MD, PhD, FRCPC, St Michael's Hospital;
Allison McGeer, MD, FRCP, Mount Sinai Hospital
285
Epidemiology and Risk Factors of Patients with Blood Stream Infection (BSI) due to Acinetobacter baumannii (AB) – A Multicenter Case-Control Study
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Paul C. Johnson, MD, Detroit Medical Center, Wayne State University;
Hardik Doshi, MBBS, Detroit Medical Center, Wayne State University;
Jing J. Zhao, PharmD, Detroit Medical Center, Wayne State University;
Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University;
Kayoko Hayakawa, MD, PhD, Detroit Medical Center, Wayne State University;
Odaliz Abreu-Lanfranco, MD, Detroit Medical Center, Wayne State University;
Sapna Parmar, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University
286
Risk Factors Associated with Extended-Spectrum β-Lactamase (ESBL) Blood Stream Infection (BSI)
Teena Chopra, MD, Detroit Medical Center, Wayne State University;
Paul C. Johnson, MD, Detroit Medical Center, Wayne State University;
Indu Chalana, MD, Detroit Medical Center, Wayne State University;
Sanjeev Patil, MD, Detroit Medical Center, Wayne State University;
Zeinab Tamam, MD, Detroit Medical Center, Wayne State University;
Mazin Mohammed, BS, Detroit Medical Center, Wayne State University;
Shatha Alkatib, MD, Detroit Medical Center, Wayne State University;
Ryan Tansek, BS, Detroit Medical Center, Wayne State University;
Khawar Chaudhry, BS, Detroit Medical Center, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
Jing J. Zhao, PharmD, Detroit Medical Center, Wayne State University;
Jason M. Pogue, PharmD, Detroit Medical Center, Wayne State University;
Sorabh Dhar, MD, Detroit Medical Center, Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University
287
Search and Destroy: A bundle Intervention for the Control of Carbapenem-Resistant Acinetobacter baumannii (CRAB) outbreaks
L. Silvia Munoz-Price, MD, University of Miami;
Gabriel Coro, RN, Jackson Memorial Hospital;
Timothy Cleary, PhD, University of Miami;
Madelaine Tamayo, RN, Jackson Memorial Hospital;
Amos Adedokum, RN, Jackson Memorial Hospital;
Lisa Francois, RN, Jackson Memorial Hospital;
Regina McDade, EdD, RN, Jackson Memorial Hospital;
Maria Socarras, RN, Jackson Memorial Hospital;
Stephen Adams, RN, Jackson Memorial Hospital;
Laurent Poirel, PhD, Hopital de Bicetre
288
Impact of consolidative antimicrobial therapy on mortality in patients with blood stream infections (BSIs) due to extended spectrum β-lactamase-producing pathogens
Jennifer Veltman, MD, Wayne State University, Detroit Medical Center, Detroit, MI;
Jing Zhao, Pharm, D, Detroit Medical Center,Wayne State University;
Ryan Tansek, BS, Wayne State University;
Dania Hatahet, MD, Detroit Medical Center,Wayne State University;
Khawar Chaudry, BS, Detroit Medical Center, Wayne State University;
Jason M. Pogue, Pharm, D, Detroit Medical Center, Wayne State University;
Ashish Bhargava, Detroit Medical Center, Wayne State University;
Ylinne Lynch, BS, Wayne State University;
Dror Marchaim, MD, Detroit Medical Center, Wayne State University;
George Alangaden, MD, Detroit Medical Center,Wayne State University;
Keith S. Kaye, MD, MPH, Detroit Medical Center, Wayne State University;
Teena Chopra, MD, Detroit Medical Center, Wayne State University
289
New Delhi Metallo-Beta-Lactamases -1 in a tertiary care pediatric center
Vikas Manchanda, MBBS, MD, Chacha Nehru Bal Chikitsalaya;
Nalini Singh, MD, Children's National Medical Center;
Nishant Verma, MD, Chacha Nehru Bal Chikitsalaya;
Rajan Chopra, MBBS, MD, Chacha Nehru Bal Chikitsalaya
290
Risk of acquiring Extended-spectrum-Beta-lactamase (ESBL) producing Klebsiella pneumoniae and Escherichia coli from prior room occupants in the intensive care unit
Adebola Ajao, MPH, University of Maryland;
J. Kristie Johnson, PhD, University of Maryland;
Anthony D. Harris, MD, MS, University of Maryland;
Min Zhan, PhD, University of Maryland;
Jessina C. McGregor, PhD, Oregon State University College of Pharmacy;
Kerri A. Thom, MD, MS, University of Maryland;
Jon P. Furuno, PhD, University of Maryland
![[ Visit SHEA online ]](images/banner.gif)